Context: Endometriosis is a chronic inflammatory disease associated with altered immune response to endometrial cells facilitating the implantation and proliferation of ectopic endometrial tissues. Although regulatory T (Treg) cells play a key role in T cell-mediated immune response and development of immune disorders, their significance in endometriosis remains to be elucidated. Results: In women with endometrioma, the proportion of activated Treg cells in the endometrioma and the endometrium, but not in the peritoneal fluid or peripheral blood, was significantly decreased compared with that in women without endometriosis. In Foxp3 DTR /diphtheria toxin mice, the number and weight of endometriotic lesions, inflammatory cytokine levels and angiogenetic factors were significantly increased compared with those in control mice.
ndometriosis is a common disease that occurs in 5% to 10% of reproductive women and is defined as the presence of endometrial tissue outside the uterus, predominantly within the peritoneal cavity, causing pelvic pain, dysmenorrhea, dyspareunia, and infertility (1) . Although emerging hypotheses concerning the histological origin of endometriosis have been presented, the exact etiology of this enigmatic disease still remains poorly understood. The implantation theory proposed by Sampson has been the most widely accepted. The retrograde reflux of menstrual endometrium through the fallopian tube might induce the implantation onto the peritoneal surface and persistence of the disease. However, explaining why only some women develop endometriosis, although most women have retrograde menstruation into the peritoneal cavity, is difficult. The alteration of the immune system in the biological process has strongly been involved in the survival and growth of ectopic endometrial fragments (2) .
The immune system has critical processes that prevent pathogen invasion. Many types of effector cells, including natural killer cells, macrophages, dendritic cells, helper T cells, and cytotoxic T cells play key roles in the activation of the immune response (3) . Regulatory T (Treg) cells are known to be a subpopulation of T cells that maintain immunological self-tolerance and homeostasis and control the suppression of excessive immune response to the host (4) . Evidence regarding the failure of the immune system contributing to the development of endometriosis has been growing. For example, peritoneal macrophages and helper T cells are elevated in local lesions of endometriosis (5) , whereas natural killer cells are reduced (6) . However, little is known regarding the significance of Treg cells in endometriosis.
Forkhead box 3 protein (Foxp3), a transcriptional factor, was discovered as a master control regulator gene for CD4 + Treg cell differentiation (7). Berbic et al. (8) showed the increased expression level of Foxp3 in eutopic and ectopic endometrial tissues of a patient with endometriosis during the secretory phase of the menstrual cycle using immunochemistry analysis. Foxp3 expression at the messenger RNA level in ovarian endometrioma tissue (9) and the relatively high CD4 +
Foxp3
+ cell ratio in CD4 + cells (10) were also confirmed. Moreover, other investigators recently showed that the percentage of CD4 +
CD25
hi Foxp3 + cells in peritoneal fluid (PF), not in peripheral blood (PB), in patients with endometriosis was significantly higher than that in patients without endometriosis (11) . From these findings, the increased Treg cell levels in local lesions have been considered to account for the abrogated immune responses in endometriosis.
In contrast, Gogacz et al. (12) Therefore, we examined the proportion of activated Treg cells in the PB, PF, and eutopic and ectopic endometrium of patients with and without endometriosis in this study. Furthermore, we also investigated whether the inducible elimination of Treg cells has influence on the proliferation and inflammatory disorder of endometriosis through immune system dysregulation using mice model (15) .
Materials and Methods

Patients and samples
Informed consent was obtained from all patients in accordance with a protocol approved by the Institutional Review Board of the Kyoto Prefectural University of Medicine (ERB-C-28-1). PB, PF, normal endometrium (NE), and eutopic endometrium with endometriosis (EE) were obtained from 55 reproductive aged (range, 20 to 45 years) patients (with endometriosis: n = 27; without endometriosis: n = 28). Ovarian endometrioma (OE) was obtained from patients with endometriosis. Patients without endometriosis underwent surgery because of leiomyoma (n = 15), ovarian dermoid cyst (n = 10), and other gynecological diseases (n = 3). Patients who were administered any hormonal and steroidal therapies within 3 months before the surgery were excluded. PB and PF samples were collected into tubes with heparin. NE, EE, and OE samples were then homogenized using Gentle MACS Dissociator (Miltenyi Biotec, Bergisch Gladbach, Germany) and centrifuged for 10 minutes at 1200g. Pellets were suspended with RPMI1640 supplemented with 2% fetal bovine serum. Lymphocytes were then isolated by Lymphoprep (Axis-Shield, Oslo, Norway), suspended by Cellbanker (Takara Bio, Shiga, Japan), and stored at 280°C using MR Frosty Container (Thermo Fisher Scientific, Waltham, MA) until flow cytometry analysis. Of 27 OE specimens, 21 were subjected for the analysis of activated Treg because the remaining sex specimens were too small for analysis. (2) and WT/DT(2) mice, respectively]. Twenty-eight mice (6 to 8 weeks old) were included and assigned to the following groups: WT/DT(2), n = 6; Foxp3 DTR /DT(2), n = 6; WT/DT, n = 8: and Foxp3 DTR /DT, n = 8.
Flow cytometry analysis
Production of endometriotic-like lesions in mice
Endometriotic-like lesions were produced based on the protocol reported previously with our modified method (16) . Briefly, both ovaries were removed from the donor and recipient mice on day 1. After the first surgery, 2 mg of estradiol valerate (Mochida Pharmaceutical, Co., Tokyo, Japan) with sesame oil was administered intramuscularly once a week. On day 8, the uterus was removed from the donor mice and minced. The fragments suspended with phosphate-buffered saline were injected into the peritoneal cavity of the recipient mice. The mice were euthanized on day 40 to confirm the production of endometriotic-like lesions.
Cell and tissue preparation
The T lymphocytes were obtained from PB of both the WT and Foxp3 DTR mice once a week. Briefly, lymph node, spleen, uterus, and endometriotic-like lesions were collected from mice and suspended with RPMI1640 with 2% fetal bovine serum. Erythrocytes were eliminated with Red Cell Lysis Buffer (SigmaAldrich, St. Louis, MO). The cells were analyzed by flow cytometry.
Enzyme-linked immunosorbent assay
The interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) concentrations in serum and PF were measured by enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN). The values were expressed as (pg/mL) for each sample, which was measured by comparing to a standard curve of IL-6 or VEGF.
Immunohistochemistry
Antibodies for Ki-67 and vimentin were used at 1/1000 dilution, and cytokeratin, an epithelial cell marker, was used at 1/2000 dilution, and ERa was used at 1/1000 dilution (17) . CD4 and Foxp3 (Wako, Osaka, Japan) were used at 1/200 and 1/500 dilutions, respectively. F4/80 (Affymetrix), a pan-macrophage marker, was used at 1/100 dilution.
RNA extraction and quantitative PCR
Total RNA was extracted using RNeasy Mini Kit (QIAGEN, Hilden, Germany). One microgram of each RNA sample was used to prepare complementary DNA using Rever Tra Ace reverse transcriptase polymerase chain reaction (PCR) kit (Toyobo, Osaka, Japan). The complementary DNA was subsequently subjected to quantitative PCR using the TaqMan gene expression kit (Life Technologies, Carlsbad, CA).
A VIC-labeled probe for glyceraldehyde-3-phosphate dehydrogenase was used for normalization.
Antibodies for flow cytometry analysis
The antihuman antibodies used for flow cytometry analysis are as follows. Anti-Foxp3 (236A/E7), anti-CD3 (UCHT1), and Fixable Viability Dye eFlour-780 (65-0865-14) were purchased from Affymetrix. Anti-CD4 (RPA-T4), anti-CD8 (SK1), anti-CD45RA (HI100), and anti-CD25 (M-A251) were purchased from BD Pharmingen (Franklin Lakes, NJ). The antimouse antibodies used for flow cytometry analysis are as follows: Fc Block (2.4G2), anti-Foxp3 (MF23), anti-CD4 (GK1.5), anti-CD8 (53-6.7), F4/80 (T45-2342), and CD11b (M1/70) were obtained from BD Pharmingen, and anti-CD3 (17A2) was obtained from Biolegend (San Diego, CA).
Statistical analysis
The differences were calculated using Student t test and one-factor analysis of variance followed by the BonferroniDunn test. P , 0.05 was considered statistically significant. Data analysis was conducted using JMP software (SAS Institute Inc., Cary, NC).
Results
Treg cell distribution in specimens from patients with and without endometriosis
Patient characteristics are shown in Fig. 2) . Interestingly, the percentage of both total and activated Treg cells in NE was significantly higher than that in PB and PF in patients without endometriosis (P , 0.01). In contrast, activated Treg cells in OE and EE in patients with endometriosis were not different from the level in PF and PB, although the percentage of total Treg cells in EE was significantly higher than that in PB and PF in patients with endometriosis [ Fig. 1(d) ].
The effect of temporary deletion of Treg cells on endometriosis development
To evaluate the effect of Treg cell elimination on the development and immune homeostasis in endometriosis, Fig. 3(a) and Fig. 3(b) ]. In contrast, no difference was found in number, weight, or size between the control mice [ Fig. 3(a) and Fig. 3(b) ]. Immunoreactivity for Ki-67 was detected in the nuclei of epithelial cells of endometriotic-like lesions. The expression of Ki-67, a representative proliferative marker, was expressed significantly higher in the Foxp3 DTR /DT mice [ Fig. 3(c) and Fig. 3(d) ] (Supplemental Figure 3) . The lesion was immunohistochemically confirmed to be composed of epithelial and stromal cells because cytokeratin and vimentin were positively stained. ERa was also positively stained, suggesting that the lesion could be estrogen dependent [ Fig. 3(d) ].
Macrophages in inducible Treg ablation mice
Macrophages that express F4/80 + and CD11b + are considered to be active. Flow cytometry and immunochemistry analysis were performed to examine macrophage expression in endometriotic-like lesions in the mice model. As shown in Fig. 4(a) and Fig. 4(b) , the expression of F4/80 + CD11b + cells in endometriotic-like lesions of Foxp3 DTR /DT mice, as well as in the spleen, was higher than that in the control mice (P , 0.01).
Recruitment of inflammatory cytokines and growth factor in mouse endometriosis model IL-6, C-C motif chemokine ligand 2 (CCL2), macrophage inflammatory protein-1 (MIP-1), and VEGF were ; N-PF, n = 18; NE, n = 28; E-PB, n = 24; E-PF, n = 20; EE, n = 27; OE, n = 21.) Data are presented as means 6 standard error of the mean (SEM) for at least six independent experiments. N, patients without endometriosis; E, patients with endometriosis. Statistical analyses are performed by one-factor analysis of variance followed by the Bonferroni-Dunn test. Significant differences are indicated as *P , 0.05 and **P , 0.01. NS, not significant.
elevated in endometriotic-like lesions in Foxp3
DTR /DT mice by quantitative PCR [ Fig. 5(a) ]. IL-6 in PF and PB were also significantly increased in Foxp3 DTR /DT mice compared with control mice [ Fig. 5(b) ]. In contrast, the VEGF level in PB and PF was not different between Foxp3 DTR /DT and WT/DT mice, although the VEGF level in endometriotic-like lesions was significantly increased [ Fig. 5(a) and Fig. 5(b) ].
Discussion
In the current study, we found that CD45RA (21), repeated failure of artificial insemination (22) , and preeclampsia (23) . In contrast, the percentage of activated Treg cells not in only OE, but also in EE, was significantly lower than NE. Accumulating evidence has demonstrated the alteration of many molecular expressions in EE (24) . Such alteration might facilitate attachment and survival of regurgitated endometrial fragments to the peritoneal mesothelium (25) . Immune system dysfunction has been strongly believed to interfere with reproductive process in endometriosis (26) . From these findings, the immune response in EE caused by the decrease of suppressive Treg cells might account not only for the development of endometriosis, but also for the high incidence of infertility in patients with endometriosis. Further examination will be needed to confirm this hypothesis. What role do "true suppressive" activated Treg cells play in the development of endometriosis? To address the issue, we established a mouse endometriosis model based on the method by Uegaki et al. (17) , although this was a model for peritoneal endometriosis, not for ovarian endometriosis as we used ovariectomized mice. The formation of endometriotic-like lesions was successfully confirmed in the abdominal cavity of mice. Our immunohistochemistry analysis also confirmed that the lesion originated from the transplanted endometrial tissues, not from the peritoneal tissues. Foxp3 has been strictly correlated with suppressive activities of Treg cells (7) . The effect of temporally inducible ablation of Treg cells on mouse endometriosis model was confirmed. Interestingly, we found that the production of endometriotic-like lesions in Foxp3 DTR /DT Treg cell ablation mice was significantly increased compared with the control mice. Proliferative capacity in endometrioticlike lesions was also significantly higher when Treg cells were reduced. In sum, the decrease of Treg cells could enhance the growth of local endometriotic cells to worsen endometriosis.
To better understand the alteration in the immune systems by Treg cell ablation in endometriosis, we next examined the expression level of macrophages.
Macrophages play critical roles in the immune responses to the presence of invaders (27) . The increase in macrophage population has been reported in PF and local endometriotic lesions, including EE and OE (28, 29) . Macrophages have been known to release locally inflammatory cytokines to promote endometriosis development (30) . However, the association of the immune balance in endometriosis with the activation of macrophage remains to be elucidated. In this study, we demonstrated that the suppressive Treg cell reduction could activate macrophage secretion in local endometriosis tissues as well as the spleen. The direct inverse correlation of the reduction of Treg cells with activation of macrophage supports the findings from other tissues, including the spleen and lymph nodes (15, 31) .
Our quantitative real-time PCR confirmed the elevation of IL-6 in PB and PF, as well as in endometrioticlike lesions in Treg cell ablation mice. These findings from a mouse model were in agreement with the results from other groups that showed elevated levels of IL-6 in PB, PF, and local tissues in patients with endometriosis (32) (33) (34) . IL-6 might have target potential for endometriosis. IL-6 (35), a multifunctional cytokine involved in the immune response and inflammation, is mainly secreted by effector T cells and macrophages. Treg cell elimination is unlikely to directly stimulate the IL-6 secretion; therefore, we propose two possibilities regarding IL-6 elevation after Treg cell elimination. One possibility is through macrophage activation. Our results showed that macrophage activation in local lesions, as well as the spleen, a representative hematopoietic tissue, is caused by Treg cell reduction. Another possibly is through the immune balance toward effector T cells by suppressive Treg cell reduction. IL-6 causes Th17 differentiation in the presence of transforming growth factor-b though CD4 + Foxp3 + Treg cell inhibition (36) . Transforming growth factor-b is upregulated in endometriosis (37) . IL-17 secreted by Th17 differentiation stimulates the proliferation of endometriotic cell growth and secretions of IL-8 and COX-2 (38) . Thus, our results suggest that the immune response via activation of both macrophage and effector T cells by suppressive Treg cell reduction contributes to endometriosis development.
IL-8 is an inflammatory cytokine secreted by macrophages that acts as chemostactic and angiogenetic factors that play important roles in the pathogenesis and development of endometriosis. Previous studies showed increased levels of IL-8 in PF from patients with endometriosis (33). Our results also showed the elevation of MIP-1 and MIP-2, IL-8 homologs in mice caused by Treg cell reduction (30) . The detailed mechanism will be clarified because no reports to date have the direct correlation of IL-8 secretion with Treg cells. In this study, we also demonstrated the stimulation of CCL2, a monocyte chemoattractant protein. Evidence has showed that CCL2, highly expressed in OE and EE, and PF in patients with endometriosis, stimulated the endometrial cell proliferation (39-42). Our results suggest that CCL2 stimulation by the decrease of Treg cells in local tissues could worsen endometriosis. VEGF plays a crucial role in angiogenesis, which is involved in pathogenesis and development of various diseases (43) . Peritoneal macrophages are the major source of VEGF in endometriosis (44) . Our study demonstrated that VEGF induction was not seen in PB, but in local tissues and PF, regardless of Treg cell reduction in the total body of mice. Indirect, secondary stimulation of VEGF, probably through macrophage activation by Treg cell reduction, has been suggested to induce angiogenesis in local endometriotic tissues.
In conclusion, we demonstrated the decrease of true suppressive activated Treg cells in women with endometriosis and progression of endometriosislike lesions by Treg cell reduction in a mouse model. Our findings challenge the previously believed contradiction that increased immune tolerance and increased immune response coexist and that both are involved in endometriosis exacerbation. Our study suggests a concept of dysregulated immune response wherein the decrease in activated Treg cells exaggerates local inflammation by activating effector T cells and macrophages, stimulates angiogenesis, and thus facilitates the progression of endometriosis. Further investigation on the immune mechanism between Treg cells and other effector T cells for etiology and development of endometriosis can be expected. Ministry of Education, Culture, Sports, Science, and Technology (Japan). Disclosure Summary: The authors have nothing to disclose.
